AzTrials
AzTrials

Fall RiskfieldNCT00767429

Development of an Acceleration Based Fall Risk Detector

A study testing fall risk detector in people with Fall Risk, run by Maastricht University Medical Center at 4 sites in Netherlands.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Because the increasing fall problem, mainly due to an impaired gait and balance ability, this study will investigate fall risk by detecting fall related movement characteristics. Read more about this study

Who is it for?
Ages 65 to 90 yearsHealthy volunteers can take part
Conditions the study is for
Fall Risk
What is being tested?
fall risk detector
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
4 sitesNetherlands
Study dates
Aug 2008to Oct 2010
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 90 years
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Having a fall risk (Tinetti score between 19-24)
  • Men and women older than 65 years at risk for falling - able to walk without walking aids - voluntary and willing to participate
  • Fully competent

Who cannot join

  • Unable to walk
  • Denying
  • Very high fall risk (Tinetti score < 19)

Trial locations and contacts

4 sites in 1 country.

Rachel Senden, drs contact

043 3881383

rachel.senden@bw.unimaas.nl

Netherlands4 sites, 4 recruiting
  • Zorgboog

    Bakel, Bakel, 5760 AA

    Marieke Lucassen, marieke.lucassen@student.unimaas.nl

    Marieke Lucassen

    Recruiting
  • University Maastricht

    Maastricht, Limburg, 6200 MD

    Rachel Senden, Drs, 0433881383, rachel.senden@bw.unimaas.nl

    Recruiting
  • Fracture and osteoporose (F&O) of the policlinical MUMC

    Maastricht, Limburg, 6229 ER

    Rachel Senden, rachel.senden@bw.unimaas.nl

    Kirsten Huntjens, K.Huntjes@AH.unimaas.nl

    Recruiting
  • Stichting Modae ZOrggrope locatie Scharwyerveld

    Maastricht, Maastricht, 6201 CA

    Lieve Van Russelt, Lieve.Vanrusselt@mosaezorggroep.nl

    Recruiting

Other trials in Netherlands

About this study

Because the increasing fall problem, mainly due to an impaired gait and balance ability, this study will investigate fall risk by detecting fall related movement characteristics. Based on the promising results using accelerometry for accurate and objective gait analysis, fall risk will be measured using a triaxial accelerometer.

At the moment our group is performing a study titled 'identify subjects at risk for falling using accelerometry'. In this study, fall related movement characteristics (gait, balance, stumble reaction) are identified in healthy younger and older subjects under standardised laboratory circumstances. In this way, specific characteristics can be selected which are responsible for fall risk.

The aim of this study is investigating if the acceleration based fall risk detector can be applied in daily life with target groups.

Read the detailed description

A first step to field measurement with target group is the measurement of elderly with a certain fall risk in a simple field condition like a nursing home.

First fall risk is assessed in elderly using the Tinetti scale (score between 19-24) which is the gold standard for fall risk assessment . This scale consist of a gait and balance score. Only subjects who have a fall risk are included for further measurements.

  1. A gait test will be performed to analyze movement parameters. Subjects have to walk 6 times a 20 meter distance at preferred speed while a small (56mmx61mmx15mm), light weight (5g) and ambulant accelerometer is attached on the sacrum with an elastic belt. The accelerometer measures accelerations of the body in three directions (antero-posterior, media-lateral and cranial-caudal) with a sample frequency of 100Hz.
  2. The balance ability will be tested by performing 4 balance tasks while the same accelerometer measures the movements of the body. Subjects have to stand with feet closed on a normal or foam surface while having the eyes open and closed.
  3. The Get Up and Go test is performed: subjects start in sitting position, have to rise, walk 3m, turn around, walk back and sit again. The time needed to perform this test is measured.
  4. 20 subjects (remaining in Scharweyerveld and Zorgboog) are monitored for one day and 20 elderly women (>70y) (recruited at the F\&O policlinic MUMC)are measured for 5 successive days, to investigate the mobility and more fall related movement parameters. The accelerometer is attached to the sacrum in the morning. First the other 2 measurements are performed, and then subjects wear the device during the whole day. The accelerometer is small, light and ambulant which is not interfering with daily activities. Subjects have to keep a diary to note all activities performed during that day. THis will be used to explain the acceleration signal.

For the subject recruited from the F\&O poli, a fall diary is kept for one year were subjects have to note when a fall has happened. In addition muscle strength in measured in this population and a questionnaire concerning quality of life (Euroqol) is completed in this group.

All acceleration data will be analyzed using specific algorithms programmed in Matlab(c). Statistical analysis will be performed in SPSS using pearson correlation to investigate correlations between gait parameters, balance characteristics and the ability perform the Get Up and Go test. Pearson correlation will also be used to validate the objective gait and balance test with the Tinetti scale. Differences in function tests between elderly at risk (measured in this study) and healthy subjects (measured in a previous study under lab conditions) will be investigated using ANOVA (p< 0.005).

Conditions
Fall Risk
Being tested
fall risk detector
Keywords
accelerometer, fall risk, target group, field measurements

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • fall risk detectorDevice

    fall risk detector: stumbles, specific fall related movements, falls

Study groups in NCT00767429
Study groupRoleWhat they receive
1Experimentalsubjects with fall risk
Receives: Device: fall risk detector

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Acceleration based movement characteristics

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Oct 2008 (estimated)
  2. Study startAug 2008
  3. Primary completionOct 2010 (estimated)
  4. Study completionOct 2010 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00767429
Sponsor's protocol ID
MEC 08-3-042
Other IDs
ABR 22858/NL22858.068.08
Acronym
field
Status last verified
Jul 2010
First submitted
1 Oct 2008
Last updated
27 Jul 2010
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing fall risk detector in people with Fall Risk, run by Maastricht University Medical Center at 4 sites in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Jul 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Rachel Senden, drs (043 3881383, rachel.senden@bw.unimaas.nl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Acceleration based movement characteristics (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jul 2010.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in